BioCryst Pharmaceuticals Inc BCRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:47 PM EDT
14.73quote price arrow up+0.03 (+0.20%)
Volume
82,554
Close
14.70quote price arrow up+0.09 (+0.62%)
Volume
1,490,145
52 week range
3.57 - 18.48
Loading...
  • Open14.60
  • Day High14.77
  • Day Low14.34
  • Prev Close14.61
  • 52 Week High18.48
  • 52 Week High Date08/06/21
  • 52 Week Low3.57
  • 52 Week Low Date10/29/20

Key Stats

  • Market Cap2.629B
  • Shares Out178.87M
  • 10 Day Average Volume2.22M
  • Dividend-
  • Dividend Yield-
  • Beta2.56
  • YTD % Change97.32

KEY STATS

  • Open14.60
  • Day High14.77
  • Day Low14.34
  • Prev Close14.61
  • 52 Week High18.48
  • 52 Week High Date08/06/21
  • 52 Week Low3.57
  • 52 Week Low Date10/29/20
  • Market Cap2.629B
  • Shares Out178.87M
  • 10 Day Average Volume2.22M
  • Dividend-
  • Dividend Yield-
  • Beta2.56
  • YTD % Change97.32

RATIOS/PROFITABILITY

  • EPS (TTM)-1.21
  • P/E (TTM)-12.16
  • Fwd P/E (NTM)-14.69
  • EBITDA (TTM)-175.504M
  • ROE (TTM)-1,925.37%
  • Revenue (TTM)79.14M
  • Gross Margin (TTM)90.10%
  • Net Margin (TTM)-270.53%
  • Debt To Equity (MRQ)-276.84%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioCryst Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BioCryst Pharmaceuticals, Inc. discovers oral and small-molecule medicines that treat rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an oral, once-daily therapy that is approved in the United States, the European Union, Japan, and the United Kingdom for the prevention of hereditary angioedema attacks in adults and pediatric patients 12 years and older. The Company has...
Robert Ingram
Non-Executive Chairman
Jon Stonehouse
Chief Executive Officer
Anthony Doyle
Chief Financial Officer
Address
4505 Emperor Blvd Ste 200
Durham, NC
27703-8457
United States

Top Peers

SYMBOLLASTCHG%CHG
AGIO
Agios Pharmaceuticals Inc
48.55+0.56+1.17%
EDIT
Editas Medicine Inc
37.82-0.65-1.69%
CYTK
Cytokinetics Inc
37.03+0.82+2.26%
KYMR
Kymera Therapeutics Inc
55.68+0.91+1.66%
PRTA
Prothena Corporation PLC
61.61+0.46+0.75%